USANA Health Sciences, Inc.
USNA
$20.03
$0.231.16%
NYSE
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.99M | 34.12M | 34.90M | 42.03M | 54.34M |
| Total Depreciation and Amortization | 35.30M | 31.29M | 27.39M | 22.23M | 21.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.64M | 8.49M | 7.52M | 9.74M | 13.39M |
| Change in Net Operating Assets | -30.41M | -10.88M | -11.01M | -13.00M | -7.72M |
| Cash from Operations | 31.52M | 63.02M | 58.79M | 60.99M | 81.23M |
| Capital Expenditure | -12.83M | -12.03M | -9.68M | -10.07M | -15.60M |
| Sale of Property, Plant, and Equipment | 0.00 | 61.00K | 61.00K | 64.00K | 66.00K |
| Cash Acquisitions | -203.34M | -203.34M | -203.34M | -203.34M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -207.00K | -207.00K | 53.00K | 255.00K | 255.00K |
| Cash from Investing | -216.37M | -215.51M | -212.90M | -213.09M | -15.27M |
| Total Debt Issued | 24.60M | 24.60M | 23.15M | 23.69M | 1.48M |
| Total Debt Repaid | -24.59M | -24.59M | -1.47M | -1.47M | -1.47M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -29.87M | -29.85M | -14.65M | -12.67M | -12.73M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.26M | -379.00K | -- | -- | 0.00 |
| Cash from Financing | -31.13M | -30.23M | 7.03M | 9.55M | -12.72M |
| Foreign Exchange rate Adjustments | -3.61M | 1.67M | -1.67M | -6.19M | 4.68M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -219.59M | -181.05M | -148.74M | -148.74M | 57.92M |